London, UK


When pharma and biotech look to develop commercially viable complement therapeutics, are you front of mind?

Key complement-based drug developers have informed us that one of the most pressing problems in this rapidly growing field is that service providers lack knowledge and experience of the industry, forcing developers to use time and resources on work that they would rather outsource.

This summit will allow sponsors to gain a deep understanding of the most pressing concerns that the industry-leading developers have with CROs, CMOs and Assay Service Providers/Vendors, and strategies for how these could be overcome. Partnering with us will enable you to meet with high-level representatives from a range of companies, hear exactly what criteria they use to select vendors, and act on these insights to offer highly tailored products and services for complement therapeutics.

This is an unparalleled opportunity to demonstrate that you have the desire and capability to meet the increasing demands of this emerging field and cement your position as the industry leader.

    • Present and position your capabilities to key decision makers from pharmaceutical developers who are actively seeking new solutions to optimise drug discovery inefficiencies
    • Meet and interact with stakeholders throughout the field trying to integrate and implement these technologies
    • Deliver a thought-leading presentation to differentiate yourself from your peers by demonstrating your specific expertise and technology
    • Meet all the business contacts you need across 3 days – take advantage of 1-2-1 networking time with your target audience

If you have a product or service that will benefit this audience, please contact Jonathan Kilby-Phillips


Phone: +44 (0)20 31418700


Email: sponsor@hansonwade.com

Alternatively, you can register your interest below:


“This summit is an excellent forum to learn about the latest technologies and innovators in the space. I enjoyed the diversity of leading speakers, providing considerable insight into the enormous potential this therapeutic area offers.”
Past CVI Summit Attendee, Abbvie